The Investing Club releases the Homestretch weekday audio feature in time for the last hour of trading on Wall Street.…
…
The expansion of Gateway Labs to San Diego reaffirms the strength and depth of the partnership between Alexandria (ARE) and…
Eli Lilly (LLY), Novo Nordisk (NVO) and Novartis (NVS) have outperformed the industry this year.…
Eli Lillys Mounjaro is significantly more effective than Novo Nordisks Ozempic in producing weight loss, a real-world study found…
Patients on Eli Lillys Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to…
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Synthetic Hormones Market: Focus on Product Type, Application, Route…
Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce are included in this Analyst Blog.…
…
Eli Lilly (LLY) plans to build a $2.5 billion manufacturing plant in Germany. Novo Nordisk (NVO) plans to invest $2.3…
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Accenture plc (ACN)…
Its a lot more likely than it sounds.…
Its a lot more likely than it sounds.…
Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimers. Mounjaro and Zepbound are expected to…
Could AstraZeneca be an under-rated buy right now?…
Could AstraZeneca be an under-rated buy right now?…
The Tema Cardiovascular and Metabolic ETF holds positions in around 20 companies, including Novo Nordisk and Eli Lilly.…
Investors have favored an exciting billion-dollar opportunity at Eli Lilly.…
Through this expansion, Eli Lilly (LLY) intends to expand its global manufacturing footprint to support the rising demand for its…
Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.…
(Amt von Hernandez im ersten Absatz korrigiert)
BERLIN (dpa-AFX) - Der US-Pharmakonzern…
(im ersten Satz des dritten Absatzes muss es korrekt Europa heißen. Zudem wurde ein Satz zu Abnehmspritzen…
Eli Lilly and Co (NYSE:LLY) has announced plans for a new $2.5 billion high-tech manufacturing site in Germany to expand…
BERLIN (dpa-AFX) - Der US-Pharmakonzern Eli Lilly will mit mehr als zwei Milliarden Euro eine…
Shares of Eli Lilly & Co. LLY rose 0.67% in premarket trading Friday after drug giant announced plans to spend…
Retail flows into Eli Lilly spiked to a more than two-year high in November, as small investors rushed to buy…
Retail investors crowd into Eli Lilly after weight-loss drug approval…
…
These companies have been attracting plenty of attention lately.…
Is it too late to invest in Eli Lillys stock?…
Is it too late to invest in Eli Lillys stock?…
Eli Lilly plans new 2 billion euro German plant -source…
U.S. pharmaceuticals company Eli Lilly plans to build a new plant in western Germany, sources close to the matter told…
…
MAINZ/ALZEY (dpa-AFX) - Der US-Pharmakonzern Eli Lilly plant einem Bericht zufolge einen Produktionsstandort in Rheinland-Pfalz.…
Despite little prescriber differentiation between the JAKs, including satisfaction and manufacturer perceptions, Olumiant is projected to maintain a significant market…
Novo Nordisk (NYSE:NVO) presented the full results from its SELECT cardiovascular trial at an American Heart Association (AHA) meeting on…
Eli Lilly and Co (NYSE:LLY)s experimental therapy lepodisiran reduced the harmful risk factor for lipoprotein (a) by up to 94%…
Prior to launch, prescribers estimate that TNF inhibitors are likely to bear the greatest brunt of increased adoption of the…
Here are Mondays biggest calls on Wall Street.…
Analysts said upcoming data on Pfizers obesity pill, danuglipron, will be crucial to how competitive the company can be against…
Both of these companies are reporting positive news for their competing weight-loss drugs, but which is the better stock to…
…
Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO),…
…
The findings could expand use of Wegovy and help Novo maintain its lead over Eli Lilly, whose competing weight-loss drug…
"The incumbent almost always wins," Jim Cramer said this week.…
Also: Bad and good results this earnings season, new tax rules, stock picks and how you too can be a…
With Eli Lilly’s Zepbound set to enter the fray, companies are flooded with weight-loss drug questions…
If management has its way, Eli Lillys earnings and share price will be way up.…